This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioPharm America
2 days in-person. 2 days virtually.
September 28–29, 2022 | Boston, USAOctober 4–5, 2022 | Virtual

HDT Bio

Profile

HDT Bio is a clinical-stage developer of RNA-based vaccines and therapeutics for infectious disease and oncology. With core intellectual property in nucleic acid formulation and delivery, the company pursues a business model of grants-funded discovery and early clinical development paired with industry collaborations, technology transfer, and commercialization. The LION formulation technology allows for flexible manufacturing, improved stability, and multiple routes of administration for nucleic acids.